BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus

MLA

Sang Hyung Lee, et al. “BAFF-Neutralizing Interaction of Belimumab Related to Its Therapeutic Efficacy for Treating Systemic Lupus Erythematosus.” Nature Communications, vol. 9, no. 1, Mar. 2018, pp. 1–11. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c2ef908e6e5495a8cd21da8eddf91768&authtype=sso&custid=ns315887.

APA

Sang Hyung Lee, Hyun Tae Lee, Woori Shin, Seong Eon Ryu, Jee Un Lee, Heejin Lim, Yong-Seok Heo, Jaejun Rhie, Ji Young Son, Ki Young Yoo, & Ju Yeon Lee. (2018). BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus. Nature Communications, 9(1), 1–11.

Chicago

Sang Hyung Lee, Hyun Tae Lee, Woori Shin, Seong Eon Ryu, Jee Un Lee, Heejin Lim, Yong-Seok Heo, et al. 2018. “BAFF-Neutralizing Interaction of Belimumab Related to Its Therapeutic Efficacy for Treating Systemic Lupus Erythematosus.” Nature Communications 9 (1): 1–11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c2ef908e6e5495a8cd21da8eddf91768&authtype=sso&custid=ns315887.